Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/9544
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSartor, Daniela Men
dc.contributor.authorVerberne, Anthony J Men
dc.date.accessioned2015-05-15T22:41:02Z
dc.date.available2015-05-15T22:41:02Z
dc.date.issued2003-10-27en
dc.identifier.citationThe Journal of Comparative Neurology; 465(4): 467-79en
dc.identifier.govdoc12975810en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/9544en
dc.description.abstractSystemic administration of the gastrointestinal hormone cholecystokinin (CCK) selectively inhibits splanchnic sympathetic vasomotor discharge and differentially affects presympathetic vasomotor neurons of the rostroventrolateral medulla (RVLM). Stimulation of the sympathoexcitatory region of the periaqueductal grey (PAG) produces profound mesenteric vasoconstriction. In this study, our aim was to identify phenotypically different populations of RVLM presympathetic vasomotor neurons using juxtacellular neuronal labelling and immunohistochemical detection of the adrenergic neuronal marker phenylethanolamine-N-methyl transferase (PNMT) and to determine whether the PAG provides functional excitatory input to these neurons. Fifty-eight percent (36/62) of RVLM presympathetic neurons were inhibited by systemic administration of CCK. These cells had conduction velocities (3.6 +/- 0.2 m/sec) in the non-C-fiber range consistent with neurons possessing lightly myelinated spinal axons. Of these, 79% (22/28) were excited by PAG stimulation, and 59% (10/17) were not immunoreactive for PNMT. Conversely, 42% (26/62) of RVLM presympathetic neurons were either unaffected or activated by CCK administration and had slower conduction velocities (1.4 +/- 0.3 m/sec) than cells inhibited by CCK. Fifty percent (11/22) of these cells were driven by PAG stimulation, and most (11/14 or 79%) were PNMT-positive. These results suggest that cardiovascular responses elicited by PAG stimulation occur via activation of non-C1 and C1 RVLM presympathetic neurons. RVLM neurons inhibited by CCK were more likely to be driven by PAG stimulation and may be a subset of neurons responsible for driving gastrointestinal sympathetic vasomotor tone. CCK-induced inhibition of a subpopulation of RVLM presympathetic neurons may be implicated in postprandial hyperemia and postprandial hypotension.en
dc.language.isoenen
dc.subject.otherAnimalsen
dc.subject.otherAxons.drug effects.physiologyen
dc.subject.otherBiotin.analogs & derivatives.diagnostic useen
dc.subject.otherBlood Pressure.drug effects.physiologyen
dc.subject.otherCell Size.physiologyen
dc.subject.otherCholecystokinin.metabolism.pharmacologyen
dc.subject.otherEfferent Pathways.cytology.drug effects.metabolismen
dc.subject.otherEpinephrine.metabolismen
dc.subject.otherMaleen
dc.subject.otherMedulla Oblongata.cytology.drug effects.metabolismen
dc.subject.otherMesenteric Arteries.innervation.physiologyen
dc.subject.otherNeural Conduction.drug effects.physiologyen
dc.subject.otherNeural Inhibition.drug effects.physiologyen
dc.subject.otherNeurons.cytology.drug effects.metabolismen
dc.subject.otherPeriaqueductal Gray.cytology.drug effects.physiologyen
dc.subject.otherPhenotypeen
dc.subject.otherPhenylethanolamine N-Methyltransferase.metabolismen
dc.subject.otherRatsen
dc.subject.otherRats, Sprague-Dawleyen
dc.subject.otherRegional Blood Flow.drug effects.physiologyen
dc.subject.otherSpinal Cord.drug effects.physiologyen
dc.subject.otherSympathetic Nervous System.cytology.drug effects.metabolismen
dc.subject.otherVasomotor System.drug effects.physiologyen
dc.titlePhenotypic identification of rat rostroventrolateral medullary presympathetic vasomotor neurons inhibited by exogenous cholecystokinin.en
dc.typeJournal Articleen
dc.identifier.journaltitleThe Journal of comparative neurologyen
dc.identifier.affiliationClinical Pharmacology and Therapeutics Unit, Austin and Repatriation Medical Centre, Department of Medicine, University of Melbourne, Heidelberg 3084, Victoria, Australiaen
dc.identifier.doi10.1002/cne.10840en
dc.description.pages467-79en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/12975810en
dc.type.austinJournal Articleen
local.name.researcherVerberne, Anthony J M
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.languageiso639-1en-
crisitem.author.deptClinical Pharmacology and Therapeutics-
crisitem.author.deptMedicine (University of Melbourne)-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

10
checked on Nov 25, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.